Search - tctmd.com

Displaying 21 - 40 of 370

Sort: Relevancy | Date

News Daily News

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Yael L. Maxwell

January 13, 2025

News Daily News

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Caitlin E. Cox

December 17, 2024

News Conference News AHA 2024

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

Michael O'Riordan

November 18, 2024

News Conference News TCT 2024

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

Yael L. Maxwell

November 01, 2024

Presentation TCT 2024

High Risk Coronary Atherosclerosis Identified by AI Algorithms and Its Prognostic Timeframe for Predicting Acute Coronary Syndromes

Presenter: Seokhun Yang

October 30, 2024

Presentation TCT 2024

TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis

Presenter: Hyun Jin Ahn

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Conference News EACTS 2024

Will Semaglutide Change Cardiac Surgery? It Already Has

Yael L. Maxwell

October 10, 2024

News Daily News

High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD

Michael O'Riordan

September 23, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

News Conference News SCCT 2024

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

Todd Neale

July 22, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

News Daily News

Atherosclerosis Progression May Share Traits With Tumor Growth

Caitlin E. Cox

May 08, 2024

News Conference News ACC 2024

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

Michael O'Riordan

April 12, 2024

News Daily News

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

L.A. McKeown

February 21, 2024

News Daily News

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Caitlin E. Cox

February 09, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Conference News

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

L.A. McKeown

February 02, 2024

Advertisement

Higher Lp(a) Indicates Greater Chance of Stenosis on CCTA in Patients With Chest Pain

Young Men Who Take Steroids Have Impaired Coronary Flow, Even After Quitting

Two Lp(a)-Lowering Therapies Clear Bar in KRAKEN and ALPACAR-360

CONFIRM2 Shows Power of AI-QCT to Use Plaque Features to Predict CAD Events

High Risk Coronary Atherosclerosis Identified by AI Algorithms and Its Prognostic Timeframe for Predicting Acute Coronary Syndromes

TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis

What’s Going to Be Big at TCT 2024?

AHA Statement Outlines Cardiac Contributions to Brain Health

Will Semaglutide Change Cardiac Surgery? It Already Has

High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD

Statins Are Cost-effective in the Elderly

Coronary Calcium Scoring May Help Get Semaglutide to Highest-Risk Patients

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Statins Effective For Primary Prevention in Old and Very Old

Atherosclerosis Progression May Share Traits With Tumor Growth

Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Real-world Data Reiterate Value of CT-First Strategy to Rule Out Obstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content